Massive study aims to slash deadly hospital infections from central lines
NCT ID NCT07255105
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow about 1,800 adult ICU patients who have a central line (a special IV placed in a large vein) to see how many get a serious bloodstream infection from it. Researchers want to find out the current infection rate and what factors increase the risk. The goal is to use this information to create better prevention steps and save lives.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLABSI - CENTRAL LINE ASSOCIATED BLOODSTREAM INFECTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongda Hospital Affiliated to Southeast University
RECRUITINGNanjing, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood infection clues: low hemoglobin and frequent sampling may raise PICC risks
- Newborn infection shield: taurolidine lock tested in 576 babies
- Can a coated catheter stop deadly ICU infections?
- Can virtual care cut hospital errors? duke launches massive study
- Massive ICU study aims to slash deadly catheter infections
- New study aims to find best catheter for fragile newborns